Geneva: The World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering Committee on Saturday, to discontinue the trials of hydroxychloroquine (HCQ) and lopinavir/ritonavir arms.
According to a press release, citing little or no reduction in the mortality rate of the hospitalised COVID-19 patients, WHO reportedly said, the decision was in light of the evidence from the Solidarity Trial’s interim results.
“These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized Covid-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect,” Xinhua reported WHO’s release.
The Solidarity Trial was established by WHO to find an effective COVID-19 treatment for patients already admitted to hospitals.
Sundargarh: Police arrested a man for allegedly killing his brother-in-law for torturing his sister in…
Mumbai: This is what you call a heavyweight collaboration. In a first-of-its-kind collaboration between rival…
Mohammad Aatif Ammad Kanth Anantnag (Jammu & Kashmir): On a chilly winter morning, Irshad Bhat…
Bhubaneswar: The former MLA of BJD from Chitrakonda in Odisha's Malkangiri district, Dambaru Sisa, on…
Bhubaneswar: The Jharkhand Mukti Morcha (JMM) has announced Anjani Soren as its candidate for Lok…
Bhubaneswar: India Energy Storage Alliance (IESA) signed a Memorandum of Understanding with Bhubaneswar City Knowledge…
Bhubaneswar: Odisha Vigilance on Thursday apprehended an officer in the collectorate of Nuapada district while…
Bhubaneswar: Odisha’s star javelin thrower Kishore Jena had a stellar season in 2023. And he’s…